{
 "cells": [
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-19T11:08:19.521015Z",
     "start_time": "2025-05-19T11:08:19.328670Z"
    }
   },
   "cell_type": "code",
   "source": [
    "import yfinance as yf\n",
    "import polars as pl\n",
    "import matplotlib.pyplot as plt"
   ],
   "outputs": [],
   "execution_count": 16
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-17T11:35:32.317294Z",
     "start_time": "2025-05-17T11:35:28.739328Z"
    }
   },
   "cell_type": "code",
   "source": [
    "stock = yf.Ticker('VRTX')\n",
    "info = stock.info"
   ],
   "outputs": [],
   "execution_count": 2
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-17T11:35:32.969874Z",
     "start_time": "2025-05-17T11:35:32.962775Z"
    }
   },
   "cell_type": "code",
   "source": "info",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'address1': '50 Northern Avenue',\n",
       " 'city': 'Boston',\n",
       " 'state': 'MA',\n",
       " 'zip': '02210',\n",
       " 'country': 'United States',\n",
       " 'phone': '617 341 6100',\n",
       " 'website': 'https://www.vrtx.com',\n",
       " 'industry': 'Biotechnology',\n",
       " 'industryKey': 'biotechnology',\n",
       " 'industryDisp': 'Biotechnology',\n",
       " 'sector': 'Healthcare',\n",
       " 'sectorKey': 'healthcare',\n",
       " 'sectorDisp': 'Healthcare',\n",
       " 'longBusinessSummary': 'Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The company also develops CASGEVY for the treatment of sickle cell disease and transfusion-dependent beta thalassemia; JOURNAVX for the treatment of acute pain in adults; VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1/2 clinical trial; inaxaplin for the treatment of APOL1-mediated kidney disease which is in single Phase 2; VX-880 and VX-264, treatment for Type 1 Diabetes; VX-670 for the treatment of myotonic dystrophy type 1; and VX-407, a small molecule corrector for the treatment of autosomal dominant polycystic kidney disease. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; and Entrada Therapeutics, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.',\n",
       " 'fullTimeEmployees': 6100,\n",
       " 'companyOfficers': [{'maxAge': 1,\n",
       "   'name': 'Dr. Jeffrey Marc Leiden M.D., Ph.D.',\n",
       "   'age': 68,\n",
       "   'title': 'Executive Chairman',\n",
       "   'yearBorn': 1956,\n",
       "   'fiscalYear': 2024,\n",
       "   'totalPay': 70000,\n",
       "   'exercisedValue': 0,\n",
       "   'unexercisedValue': 0},\n",
       "  {'maxAge': 1,\n",
       "   'name': 'Dr. Reshma  Kewalramani FASN, M.D.',\n",
       "   'age': 51,\n",
       "   'title': 'CEO, President & Director',\n",
       "   'yearBorn': 1973,\n",
       "   'fiscalYear': 2024,\n",
       "   'totalPay': 6536466,\n",
       "   'exercisedValue': 421721,\n",
       "   'unexercisedValue': 0},\n",
       "  {'maxAge': 1,\n",
       "   'name': 'Mr. Charles F. Wagner Jr.',\n",
       "   'age': 56,\n",
       "   'title': 'Executive VP & CFO',\n",
       "   'yearBorn': 1968,\n",
       "   'fiscalYear': 2024,\n",
       "   'totalPay': 2749112,\n",
       "   'exercisedValue': 0,\n",
       "   'unexercisedValue': 2033366},\n",
       "  {'maxAge': 1,\n",
       "   'name': 'Mr. Stuart A. Arbuckle B.Sc.',\n",
       "   'age': 58,\n",
       "   'title': 'Executive VP & COO',\n",
       "   'yearBorn': 1966,\n",
       "   'fiscalYear': 2024,\n",
       "   'totalPay': 3148606,\n",
       "   'exercisedValue': 0,\n",
       "   'unexercisedValue': 0},\n",
       "  {'maxAge': 1,\n",
       "   'name': 'Dr. David M. Altshuler M.D., Ph.D.',\n",
       "   'age': 59,\n",
       "   'title': 'Executive VP & Chief Scientific Officer',\n",
       "   'yearBorn': 1965,\n",
       "   'fiscalYear': 2024,\n",
       "   'totalPay': 2387150,\n",
       "   'exercisedValue': 0,\n",
       "   'unexercisedValue': 0},\n",
       "  {'maxAge': 1,\n",
       "   'name': 'Dr. Ourania  Tatsis Ph.D.',\n",
       "   'age': 54,\n",
       "   'title': 'Executive VP and Chief Regulatory & Quality Officer',\n",
       "   'yearBorn': 1970,\n",
       "   'fiscalYear': 2024,\n",
       "   'totalPay': 2083988,\n",
       "   'exercisedValue': 0,\n",
       "   'unexercisedValue': 2027529},\n",
       "  {'maxAge': 1,\n",
       "   'name': 'Ms. Kristen C. Ambrose CPA',\n",
       "   'age': 47,\n",
       "   'title': 'Senior VP & Chief Accounting Officer',\n",
       "   'yearBorn': 1977,\n",
       "   'fiscalYear': 2024,\n",
       "   'exercisedValue': 0,\n",
       "   'unexercisedValue': 0},\n",
       "  {'maxAge': 1,\n",
       "   'name': 'Ms. Susie  Lisa C.F.A.',\n",
       "   'title': 'Senior Vice President of Investor Relations',\n",
       "   'fiscalYear': 2024,\n",
       "   'exercisedValue': 0,\n",
       "   'unexercisedValue': 0},\n",
       "  {'maxAge': 1,\n",
       "   'name': 'Mr. Jonathan  Biller J.D.',\n",
       "   'age': 59,\n",
       "   'title': 'Executive VP & Chief Legal Officer',\n",
       "   'yearBorn': 1965,\n",
       "   'fiscalYear': 2024,\n",
       "   'exercisedValue': 0,\n",
       "   'unexercisedValue': 0},\n",
       "  {'maxAge': 1,\n",
       "   'name': 'Ms. Nina  Devlin',\n",
       "   'title': 'Senior VP & Chief Communications Officer',\n",
       "   'fiscalYear': 2024,\n",
       "   'exercisedValue': 0,\n",
       "   'unexercisedValue': 0}],\n",
       " 'auditRisk': 6,\n",
       " 'boardRisk': 6,\n",
       " 'compensationRisk': 6,\n",
       " 'shareHolderRightsRisk': 6,\n",
       " 'overallRisk': 6,\n",
       " 'governanceEpochDate': 1746057600,\n",
       " 'compensationAsOfEpochDate': 1735603200,\n",
       " 'irWebsite': 'http://www.vrtx.com/finances.html',\n",
       " 'executiveTeam': [],\n",
       " 'maxAge': 86400,\n",
       " 'priceHint': 2,\n",
       " 'previousClose': 434.38,\n",
       " 'open': 435.3,\n",
       " 'dayLow': 429.94,\n",
       " 'dayHigh': 438.95,\n",
       " 'regularMarketPreviousClose': 434.38,\n",
       " 'regularMarketOpen': 435.3,\n",
       " 'regularMarketDayLow': 429.94,\n",
       " 'regularMarketDayHigh': 438.95,\n",
       " 'payoutRatio': 0.0,\n",
       " 'beta': 0.513,\n",
       " 'forwardPE': 23.369738,\n",
       " 'volume': 1378041,\n",
       " 'regularMarketVolume': 1378041,\n",
       " 'averageVolume': 1721840,\n",
       " 'averageVolume10days': 2863860,\n",
       " 'averageDailyVolume10Day': 2863860,\n",
       " 'bid': 413.5,\n",
       " 'ask': 452.25,\n",
       " 'bidSize': 1,\n",
       " 'askSize': 1,\n",
       " 'marketCap': 112643997696,\n",
       " 'fiftyTwoWeekLow': 377.85,\n",
       " 'fiftyTwoWeekHigh': 519.88,\n",
       " 'priceToSalesTrailing12Months': 10.148382,\n",
       " 'fiftyDayAverage': 484.567,\n",
       " 'twoHundredDayAverage': 469.1925,\n",
       " 'trailingAnnualDividendRate': 0.0,\n",
       " 'trailingAnnualDividendYield': 0.0,\n",
       " 'currency': 'USD',\n",
       " 'tradeable': False,\n",
       " 'enterpriseValue': 108091990016,\n",
       " 'profitMargins': -0.089090005,\n",
       " 'floatShares': 256075587,\n",
       " 'sharesOutstanding': 256796992,\n",
       " 'sharesShort': 3780307,\n",
       " 'sharesShortPriorMonth': 4463380,\n",
       " 'sharesShortPreviousMonthDate': 1743379200,\n",
       " 'dateShortInterest': 1745971200,\n",
       " 'sharesPercentSharesOut': 0.0147,\n",
       " 'heldPercentInsiders': 0.0014,\n",
       " 'heldPercentInstitutions': 0.97826,\n",
       " 'shortRatio': 2.24,\n",
       " 'shortPercentOfFloat': 0.0166,\n",
       " 'impliedSharesOutstanding': 256796992,\n",
       " 'bookValue': 64.196,\n",
       " 'priceToBook': 6.83298,\n",
       " 'lastFiscalYearEnd': 1735603200,\n",
       " 'nextFiscalYearEnd': 1767139200,\n",
       " 'mostRecentQuarter': 1743379200,\n",
       " 'earningsQuarterlyGrowth': -0.412,\n",
       " 'netIncomeToCommon': -988899968,\n",
       " 'trailingEps': -3.82,\n",
       " 'forwardEps': 18.77,\n",
       " 'lastSplitFactor': '2:1',\n",
       " 'lastSplitDate': 967075200,\n",
       " 'enterpriseToRevenue': 9.738,\n",
       " 'enterpriseToEbitda': 23.578,\n",
       " '52WeekChange': -0.02576983,\n",
       " 'SandP52WeekChange': 0.11469197,\n",
       " 'quoteType': 'EQUITY',\n",
       " 'currentPrice': 438.65,\n",
       " 'targetHighPrice': 621.0,\n",
       " 'targetLowPrice': 330.0,\n",
       " 'targetMeanPrice': 500.29785,\n",
       " 'targetMedianPrice': 512.5,\n",
       " 'recommendationMean': 2.14706,\n",
       " 'recommendationKey': 'buy',\n",
       " 'numberOfAnalystOpinions': 28,\n",
       " 'totalCash': 6201200128,\n",
       " 'totalCashPerShare': 24.148,\n",
       " 'ebitda': 4584399872,\n",
       " 'totalDebt': 1649100032,\n",
       " 'quickRatio': 2.116,\n",
       " 'currentRatio': 2.646,\n",
       " 'totalRevenue': 11099700224,\n",
       " 'debtToEquity': 9.997,\n",
       " 'revenuePerShare': 43.093,\n",
       " 'returnOnAssets': 0.11773,\n",
       " 'returnOnEquity': -0.05644,\n",
       " 'grossProfits': 5892899840,\n",
       " 'freeCashflow': 2634387456,\n",
       " 'operatingCashflow': -980300032,\n",
       " 'earningsGrowth': -0.409,\n",
       " 'revenueGrowth': 0.03,\n",
       " 'grossMargins': 0.53091,\n",
       " 'ebitdaMargins': 0.41301998,\n",
       " 'operatingMargins': 0.37221,\n",
       " 'financialCurrency': 'USD',\n",
       " 'symbol': 'VRTX',\n",
       " 'language': 'en-US',\n",
       " 'region': 'US',\n",
       " 'typeDisp': 'Equity',\n",
       " 'quoteSourceName': 'Nasdaq Real Time Price',\n",
       " 'triggerable': True,\n",
       " 'customPriceAlertConfidence': 'HIGH',\n",
       " 'marketState': 'CLOSED',\n",
       " 'shortName': 'Vertex Pharmaceuticals Incorpor',\n",
       " 'longName': 'Vertex Pharmaceuticals Incorporated',\n",
       " 'cryptoTradeable': False,\n",
       " 'corporateActions': [],\n",
       " 'postMarketTime': 1747439679,\n",
       " 'regularMarketTime': 1747425601,\n",
       " 'exchange': 'NMS',\n",
       " 'messageBoardId': 'finmb_36235',\n",
       " 'exchangeTimezoneName': 'America/New_York',\n",
       " 'exchangeTimezoneShortName': 'EDT',\n",
       " 'gmtOffSetMilliseconds': -14400000,\n",
       " 'market': 'us_market',\n",
       " 'esgPopulated': False,\n",
       " 'hasPrePostMarketData': True,\n",
       " 'firstTradeDateMilliseconds': 680362200000,\n",
       " 'postMarketChangePercent': -0.681635,\n",
       " 'postMarketPrice': 435.66,\n",
       " 'postMarketChange': -2.98999,\n",
       " 'regularMarketChange': 4.269989,\n",
       " 'regularMarketDayRange': '429.94 - 438.95',\n",
       " 'fullExchangeName': 'NasdaqGS',\n",
       " 'averageDailyVolume3Month': 1721840,\n",
       " 'fiftyTwoWeekLowChange': 60.799988,\n",
       " 'fiftyTwoWeekLowChangePercent': 0.16091038,\n",
       " 'fiftyTwoWeekRange': '377.85 - 519.88',\n",
       " 'fiftyTwoWeekHighChange': -81.23001,\n",
       " 'fiftyTwoWeekHighChangePercent': -0.15624762,\n",
       " 'fiftyTwoWeekChangePercent': -2.576983,\n",
       " 'earningsTimestamp': 1746475260,\n",
       " 'earningsTimestampStart': 1753873140,\n",
       " 'earningsTimestampEnd': 1754308800,\n",
       " 'earningsCallTimestampStart': 1746477000,\n",
       " 'earningsCallTimestampEnd': 1746477000,\n",
       " 'isEarningsDateEstimate': True,\n",
       " 'epsTrailingTwelveMonths': -3.82,\n",
       " 'epsForward': 18.77,\n",
       " 'epsCurrentYear': 18.0042,\n",
       " 'priceEpsCurrentYear': 24.36376,\n",
       " 'fiftyDayAverageChange': -45.916992,\n",
       " 'fiftyDayAverageChangePercent': -0.094758816,\n",
       " 'twoHundredDayAverageChange': -30.542511,\n",
       " 'twoHundredDayAverageChangePercent': -0.06509591,\n",
       " 'sourceInterval': 15,\n",
       " 'exchangeDataDelayedBy': 0,\n",
       " 'averageAnalystRating': '2.1 - Buy',\n",
       " 'regularMarketChangePercent': 0.9830077,\n",
       " 'regularMarketPrice': 438.65,\n",
       " 'trailingPegRatio': 2.6106}"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 3
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-19T10:19:51.177939Z",
     "start_time": "2025-05-19T10:19:51.153554Z"
    }
   },
   "cell_type": "code",
   "source": "data = pl.read_csv('data/w1fs4jrazjijad60.csv.gz')",
   "outputs": [],
   "execution_count": 2
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-19T10:21:57.916191Z",
     "start_time": "2025-05-19T10:21:57.905252Z"
    }
   },
   "cell_type": "code",
   "source": "data.head(20).write_csv('data/example.csv')",
   "outputs": [],
   "execution_count": 9
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-19T11:08:23.900040Z",
     "start_time": "2025-05-19T11:08:23.879962Z"
    }
   },
   "cell_type": "code",
   "source": "vrtx = pl.read_csv('data/vrtx.csv.gz')",
   "outputs": [],
   "execution_count": 17
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-19T11:08:53.033097Z",
     "start_time": "2025-05-19T11:08:53.024192Z"
    }
   },
   "cell_type": "code",
   "source": "vrtx.head(20)",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "shape: (20, 76)\n",
       "┌───────┬─────┬────────────┬──────┬───┬──────┬──────────────┬───────┬────────────┐\n",
       "│ gvkey ┆ iid ┆ datadate   ┆ tic  ┆ … ┆ stko ┆ weburl       ┆ dldte ┆ ipodate    │\n",
       "│ ---   ┆ --- ┆ ---        ┆ ---  ┆   ┆ ---  ┆ ---          ┆ ---   ┆ ---        │\n",
       "│ i64   ┆ i64 ┆ str        ┆ str  ┆   ┆ i64  ┆ str          ┆ str   ┆ str        │\n",
       "╞═══════╪═════╪════════════╪══════╪═══╪══════╪══════════════╪═══════╪════════════╡\n",
       "│ 24344 ┆ 1   ┆ 2000-01-03 ┆ VRTX ┆ … ┆ 0    ┆ www.vrtx.com ┆ null  ┆ 1991-07-24 │\n",
       "│ 24344 ┆ 1   ┆ 2000-01-04 ┆ VRTX ┆ … ┆ 0    ┆ www.vrtx.com ┆ null  ┆ 1991-07-24 │\n",
       "│ 24344 ┆ 1   ┆ 2000-01-05 ┆ VRTX ┆ … ┆ 0    ┆ www.vrtx.com ┆ null  ┆ 1991-07-24 │\n",
       "│ 24344 ┆ 1   ┆ 2000-01-06 ┆ VRTX ┆ … ┆ 0    ┆ www.vrtx.com ┆ null  ┆ 1991-07-24 │\n",
       "│ 24344 ┆ 1   ┆ 2000-01-07 ┆ VRTX ┆ … ┆ 0    ┆ www.vrtx.com ┆ null  ┆ 1991-07-24 │\n",
       "│ …     ┆ …   ┆ …          ┆ …    ┆ … ┆ …    ┆ …            ┆ …     ┆ …          │\n",
       "│ 24344 ┆ 1   ┆ 2000-01-25 ┆ VRTX ┆ … ┆ 0    ┆ www.vrtx.com ┆ null  ┆ 1991-07-24 │\n",
       "│ 24344 ┆ 1   ┆ 2000-01-26 ┆ VRTX ┆ … ┆ 0    ┆ www.vrtx.com ┆ null  ┆ 1991-07-24 │\n",
       "│ 24344 ┆ 1   ┆ 2000-01-27 ┆ VRTX ┆ … ┆ 0    ┆ www.vrtx.com ┆ null  ┆ 1991-07-24 │\n",
       "│ 24344 ┆ 1   ┆ 2000-01-28 ┆ VRTX ┆ … ┆ 0    ┆ www.vrtx.com ┆ null  ┆ 1991-07-24 │\n",
       "│ 24344 ┆ 1   ┆ 2000-01-31 ┆ VRTX ┆ … ┆ 0    ┆ www.vrtx.com ┆ null  ┆ 1991-07-24 │\n",
       "└───────┴─────┴────────────┴──────┴───┴──────┴──────────────┴───────┴────────────┘"
      ],
      "text/html": [
       "<div><style>\n",
       ".dataframe > thead > tr,\n",
       ".dataframe > tbody > tr {\n",
       "  text-align: right;\n",
       "  white-space: pre-wrap;\n",
       "}\n",
       "</style>\n",
       "<small>shape: (20, 76)</small><table border=\"1\" class=\"dataframe\"><thead><tr><th>gvkey</th><th>iid</th><th>datadate</th><th>tic</th><th>cusip</th><th>conm</th><th>curcddv</th><th>capgn</th><th>cheqv</th><th>div</th><th>divd</th><th>divdpaydateind</th><th>divsp</th><th>dvrated</th><th>paydateind</th><th>anncdate</th><th>capgnpaydate</th><th>cheqvpaydate</th><th>divdpaydate</th><th>divsppaydate</th><th>paydate</th><th>recorddate</th><th>curcdd</th><th>adrrc</th><th>ajexdi</th><th>cshoc</th><th>cshtrd</th><th>dvi</th><th>eps</th><th>epsmo</th><th>prccd</th><th>prchd</th><th>prcld</th><th>prcod</th><th>prcstd</th><th>trfd</th><th>exchg</th><th>&hellip;</th><th>cik</th><th>fic</th><th>add1</th><th>add2</th><th>add3</th><th>add4</th><th>addzip</th><th>busdesc</th><th>city</th><th>conml</th><th>costat</th><th>county</th><th>dlrsn</th><th>ein</th><th>fax</th><th>fyrc</th><th>ggroup</th><th>gind</th><th>gsector</th><th>gsubind</th><th>idbflag</th><th>incorp</th><th>loc</th><th>naics</th><th>phone</th><th>prican</th><th>prirow</th><th>priusa</th><th>sic</th><th>spcindcd</th><th>spcseccd</th><th>spcsrc</th><th>state</th><th>stko</th><th>weburl</th><th>dldte</th><th>ipodate</th></tr><tr><td>i64</td><td>i64</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>f64</td><td>i64</td><td>f64</td><td>str</td><td>f64</td><td>i64</td><td>f64</td><td>f64</td><td>f64</td><td>str</td><td>i64</td><td>str</td><td>i64</td><td>&hellip;</td><td>i64</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>i64</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>str</td><td>i64</td><td>i64</td><td>i64</td><td>i64</td><td>i64</td><td>str</td><td>str</td><td>str</td><td>i64</td><td>str</td><td>str</td><td>str</td><td>i64</td><td>i64</td><td>i64</td><td>i64</td><td>str</td><td>str</td><td>i64</td><td>str</td><td>str</td><td>str</td></tr></thead><tbody><tr><td>24344</td><td>1</td><td>&quot;2000-01-03&quot;</td><td>&quot;VRTX&quot;</td><td>&quot;92532F100&quot;</td><td>&quot;VERTEX PHARMACEUTICALS INC&quot;</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>&quot;USD&quot;</td><td>null</td><td>2.0</td><td>25644000</td><td>505000.0</td><td>null</td><td>-2.18</td><td>9</td><td>37.5625</td><td>37.5625</td><td>33.625</td><td>null</td><td>3</td><td>null</td><td>14</td><td>&hellip;</td><td>875320</td><td>&quot;USA&quot;</td><td>&quot;50 Northern Avenue&quot;</td><td>null</td><td>null</td><td>null</td><td>2210</td><td>&quot;Vertex Pharmaceuticals Incorpo…</td><td>&quot;Boston&quot;</td><td>&quot;Vertex Pharmaceuticals Inc&quot;</td><td>&quot;A&quot;</td><td>null</td><td>null</td><td>&quot;04-3039129&quot;</td><td>null</td><td>12</td><td>3520</td><td>352010</td><td>35</td><td>35201010</td><td>&quot;B&quot;</td><td>&quot;MA&quot;</td><td>&quot;USA&quot;</td><td>325414</td><td>&quot;617 341 6100&quot;</td><td>null</td><td>null</td><td>1</td><td>2836</td><td>147</td><td>905</td><td>&quot;C&quot;</td><td>&quot;MA&quot;</td><td>0</td><td>&quot;www.vrtx.com&quot;</td><td>null</td><td>&quot;1991-07-24&quot;</td></tr><tr><td>24344</td><td>1</td><td>&quot;2000-01-04&quot;</td><td>&quot;VRTX&quot;</td><td>&quot;92532F100&quot;</td><td>&quot;VERTEX PHARMACEUTICALS INC&quot;</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>&quot;USD&quot;</td><td>null</td><td>2.0</td><td>25644000</td><td>132700.0</td><td>null</td><td>-2.18</td><td>9</td><td>34.5625</td><td>36.625</td><td>34.5</td><td>null</td><td>3</td><td>null</td><td>14</td><td>&hellip;</td><td>875320</td><td>&quot;USA&quot;</td><td>&quot;50 Northern Avenue&quot;</td><td>null</td><td>null</td><td>null</td><td>2210</td><td>&quot;Vertex Pharmaceuticals Incorpo…</td><td>&quot;Boston&quot;</td><td>&quot;Vertex Pharmaceuticals Inc&quot;</td><td>&quot;A&quot;</td><td>null</td><td>null</td><td>&quot;04-3039129&quot;</td><td>null</td><td>12</td><td>3520</td><td>352010</td><td>35</td><td>35201010</td><td>&quot;B&quot;</td><td>&quot;MA&quot;</td><td>&quot;USA&quot;</td><td>325414</td><td>&quot;617 341 6100&quot;</td><td>null</td><td>null</td><td>1</td><td>2836</td><td>147</td><td>905</td><td>&quot;C&quot;</td><td>&quot;MA&quot;</td><td>0</td><td>&quot;www.vrtx.com&quot;</td><td>null</td><td>&quot;1991-07-24&quot;</td></tr><tr><td>24344</td><td>1</td><td>&quot;2000-01-05&quot;</td><td>&quot;VRTX&quot;</td><td>&quot;92532F100&quot;</td><td>&quot;VERTEX PHARMACEUTICALS INC&quot;</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>&quot;USD&quot;</td><td>null</td><td>2.0</td><td>25644000</td><td>101000.0</td><td>null</td><td>-2.18</td><td>9</td><td>34.0</td><td>34.25</td><td>33.0</td><td>null</td><td>3</td><td>null</td><td>14</td><td>&hellip;</td><td>875320</td><td>&quot;USA&quot;</td><td>&quot;50 Northern Avenue&quot;</td><td>null</td><td>null</td><td>null</td><td>2210</td><td>&quot;Vertex Pharmaceuticals Incorpo…</td><td>&quot;Boston&quot;</td><td>&quot;Vertex Pharmaceuticals Inc&quot;</td><td>&quot;A&quot;</td><td>null</td><td>null</td><td>&quot;04-3039129&quot;</td><td>null</td><td>12</td><td>3520</td><td>352010</td><td>35</td><td>35201010</td><td>&quot;B&quot;</td><td>&quot;MA&quot;</td><td>&quot;USA&quot;</td><td>325414</td><td>&quot;617 341 6100&quot;</td><td>null</td><td>null</td><td>1</td><td>2836</td><td>147</td><td>905</td><td>&quot;C&quot;</td><td>&quot;MA&quot;</td><td>0</td><td>&quot;www.vrtx.com&quot;</td><td>null</td><td>&quot;1991-07-24&quot;</td></tr><tr><td>24344</td><td>1</td><td>&quot;2000-01-06&quot;</td><td>&quot;VRTX&quot;</td><td>&quot;92532F100&quot;</td><td>&quot;VERTEX PHARMACEUTICALS INC&quot;</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>&quot;USD&quot;</td><td>null</td><td>2.0</td><td>25644000</td><td>135400.0</td><td>null</td><td>-2.18</td><td>9</td><td>33.5</td><td>33.875</td><td>33.125</td><td>null</td><td>3</td><td>null</td><td>14</td><td>&hellip;</td><td>875320</td><td>&quot;USA&quot;</td><td>&quot;50 Northern Avenue&quot;</td><td>null</td><td>null</td><td>null</td><td>2210</td><td>&quot;Vertex Pharmaceuticals Incorpo…</td><td>&quot;Boston&quot;</td><td>&quot;Vertex Pharmaceuticals Inc&quot;</td><td>&quot;A&quot;</td><td>null</td><td>null</td><td>&quot;04-3039129&quot;</td><td>null</td><td>12</td><td>3520</td><td>352010</td><td>35</td><td>35201010</td><td>&quot;B&quot;</td><td>&quot;MA&quot;</td><td>&quot;USA&quot;</td><td>325414</td><td>&quot;617 341 6100&quot;</td><td>null</td><td>null</td><td>1</td><td>2836</td><td>147</td><td>905</td><td>&quot;C&quot;</td><td>&quot;MA&quot;</td><td>0</td><td>&quot;www.vrtx.com&quot;</td><td>null</td><td>&quot;1991-07-24&quot;</td></tr><tr><td>24344</td><td>1</td><td>&quot;2000-01-07&quot;</td><td>&quot;VRTX&quot;</td><td>&quot;92532F100&quot;</td><td>&quot;VERTEX PHARMACEUTICALS INC&quot;</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>&quot;USD&quot;</td><td>null</td><td>2.0</td><td>25644000</td><td>406600.0</td><td>null</td><td>-2.18</td><td>9</td><td>36.4375</td><td>37.0</td><td>33.0</td><td>null</td><td>3</td><td>null</td><td>14</td><td>&hellip;</td><td>875320</td><td>&quot;USA&quot;</td><td>&quot;50 Northern Avenue&quot;</td><td>null</td><td>null</td><td>null</td><td>2210</td><td>&quot;Vertex Pharmaceuticals Incorpo…</td><td>&quot;Boston&quot;</td><td>&quot;Vertex Pharmaceuticals Inc&quot;</td><td>&quot;A&quot;</td><td>null</td><td>null</td><td>&quot;04-3039129&quot;</td><td>null</td><td>12</td><td>3520</td><td>352010</td><td>35</td><td>35201010</td><td>&quot;B&quot;</td><td>&quot;MA&quot;</td><td>&quot;USA&quot;</td><td>325414</td><td>&quot;617 341 6100&quot;</td><td>null</td><td>null</td><td>1</td><td>2836</td><td>147</td><td>905</td><td>&quot;C&quot;</td><td>&quot;MA&quot;</td><td>0</td><td>&quot;www.vrtx.com&quot;</td><td>null</td><td>&quot;1991-07-24&quot;</td></tr><tr><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td><td>&hellip;</td></tr><tr><td>24344</td><td>1</td><td>&quot;2000-01-25&quot;</td><td>&quot;VRTX&quot;</td><td>&quot;92532F100&quot;</td><td>&quot;VERTEX PHARMACEUTICALS INC&quot;</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>&quot;USD&quot;</td><td>null</td><td>2.0</td><td>25644000</td><td>310400.0</td><td>null</td><td>-2.18</td><td>9</td><td>44.25</td><td>49.75</td><td>43.0</td><td>null</td><td>3</td><td>null</td><td>14</td><td>&hellip;</td><td>875320</td><td>&quot;USA&quot;</td><td>&quot;50 Northern Avenue&quot;</td><td>null</td><td>null</td><td>null</td><td>2210</td><td>&quot;Vertex Pharmaceuticals Incorpo…</td><td>&quot;Boston&quot;</td><td>&quot;Vertex Pharmaceuticals Inc&quot;</td><td>&quot;A&quot;</td><td>null</td><td>null</td><td>&quot;04-3039129&quot;</td><td>null</td><td>12</td><td>3520</td><td>352010</td><td>35</td><td>35201010</td><td>&quot;B&quot;</td><td>&quot;MA&quot;</td><td>&quot;USA&quot;</td><td>325414</td><td>&quot;617 341 6100&quot;</td><td>null</td><td>null</td><td>1</td><td>2836</td><td>147</td><td>905</td><td>&quot;C&quot;</td><td>&quot;MA&quot;</td><td>0</td><td>&quot;www.vrtx.com&quot;</td><td>null</td><td>&quot;1991-07-24&quot;</td></tr><tr><td>24344</td><td>1</td><td>&quot;2000-01-26&quot;</td><td>&quot;VRTX&quot;</td><td>&quot;92532F100&quot;</td><td>&quot;VERTEX PHARMACEUTICALS INC&quot;</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>&quot;USD&quot;</td><td>null</td><td>2.0</td><td>25644000</td><td>388600.0</td><td>null</td><td>-2.18</td><td>9</td><td>44.25</td><td>47.125</td><td>44.0</td><td>null</td><td>3</td><td>null</td><td>14</td><td>&hellip;</td><td>875320</td><td>&quot;USA&quot;</td><td>&quot;50 Northern Avenue&quot;</td><td>null</td><td>null</td><td>null</td><td>2210</td><td>&quot;Vertex Pharmaceuticals Incorpo…</td><td>&quot;Boston&quot;</td><td>&quot;Vertex Pharmaceuticals Inc&quot;</td><td>&quot;A&quot;</td><td>null</td><td>null</td><td>&quot;04-3039129&quot;</td><td>null</td><td>12</td><td>3520</td><td>352010</td><td>35</td><td>35201010</td><td>&quot;B&quot;</td><td>&quot;MA&quot;</td><td>&quot;USA&quot;</td><td>325414</td><td>&quot;617 341 6100&quot;</td><td>null</td><td>null</td><td>1</td><td>2836</td><td>147</td><td>905</td><td>&quot;C&quot;</td><td>&quot;MA&quot;</td><td>0</td><td>&quot;www.vrtx.com&quot;</td><td>null</td><td>&quot;1991-07-24&quot;</td></tr><tr><td>24344</td><td>1</td><td>&quot;2000-01-27&quot;</td><td>&quot;VRTX&quot;</td><td>&quot;92532F100&quot;</td><td>&quot;VERTEX PHARMACEUTICALS INC&quot;</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>&quot;USD&quot;</td><td>null</td><td>2.0</td><td>25644000</td><td>280300.0</td><td>null</td><td>-2.18</td><td>9</td><td>42.0625</td><td>46.5</td><td>41.25</td><td>null</td><td>3</td><td>null</td><td>14</td><td>&hellip;</td><td>875320</td><td>&quot;USA&quot;</td><td>&quot;50 Northern Avenue&quot;</td><td>null</td><td>null</td><td>null</td><td>2210</td><td>&quot;Vertex Pharmaceuticals Incorpo…</td><td>&quot;Boston&quot;</td><td>&quot;Vertex Pharmaceuticals Inc&quot;</td><td>&quot;A&quot;</td><td>null</td><td>null</td><td>&quot;04-3039129&quot;</td><td>null</td><td>12</td><td>3520</td><td>352010</td><td>35</td><td>35201010</td><td>&quot;B&quot;</td><td>&quot;MA&quot;</td><td>&quot;USA&quot;</td><td>325414</td><td>&quot;617 341 6100&quot;</td><td>null</td><td>null</td><td>1</td><td>2836</td><td>147</td><td>905</td><td>&quot;C&quot;</td><td>&quot;MA&quot;</td><td>0</td><td>&quot;www.vrtx.com&quot;</td><td>null</td><td>&quot;1991-07-24&quot;</td></tr><tr><td>24344</td><td>1</td><td>&quot;2000-01-28&quot;</td><td>&quot;VRTX&quot;</td><td>&quot;92532F100&quot;</td><td>&quot;VERTEX PHARMACEUTICALS INC&quot;</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>&quot;USD&quot;</td><td>null</td><td>2.0</td><td>25644000</td><td>156300.0</td><td>null</td><td>-2.18</td><td>9</td><td>41.71875</td><td>42.25</td><td>40.625</td><td>null</td><td>3</td><td>null</td><td>14</td><td>&hellip;</td><td>875320</td><td>&quot;USA&quot;</td><td>&quot;50 Northern Avenue&quot;</td><td>null</td><td>null</td><td>null</td><td>2210</td><td>&quot;Vertex Pharmaceuticals Incorpo…</td><td>&quot;Boston&quot;</td><td>&quot;Vertex Pharmaceuticals Inc&quot;</td><td>&quot;A&quot;</td><td>null</td><td>null</td><td>&quot;04-3039129&quot;</td><td>null</td><td>12</td><td>3520</td><td>352010</td><td>35</td><td>35201010</td><td>&quot;B&quot;</td><td>&quot;MA&quot;</td><td>&quot;USA&quot;</td><td>325414</td><td>&quot;617 341 6100&quot;</td><td>null</td><td>null</td><td>1</td><td>2836</td><td>147</td><td>905</td><td>&quot;C&quot;</td><td>&quot;MA&quot;</td><td>0</td><td>&quot;www.vrtx.com&quot;</td><td>null</td><td>&quot;1991-07-24&quot;</td></tr><tr><td>24344</td><td>1</td><td>&quot;2000-01-31&quot;</td><td>&quot;VRTX&quot;</td><td>&quot;92532F100&quot;</td><td>&quot;VERTEX PHARMACEUTICALS INC&quot;</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>null</td><td>&quot;USD&quot;</td><td>null</td><td>2.0</td><td>25644000</td><td>246200.0</td><td>null</td><td>-2.18</td><td>9</td><td>41.0</td><td>41.875</td><td>39.875</td><td>null</td><td>3</td><td>null</td><td>14</td><td>&hellip;</td><td>875320</td><td>&quot;USA&quot;</td><td>&quot;50 Northern Avenue&quot;</td><td>null</td><td>null</td><td>null</td><td>2210</td><td>&quot;Vertex Pharmaceuticals Incorpo…</td><td>&quot;Boston&quot;</td><td>&quot;Vertex Pharmaceuticals Inc&quot;</td><td>&quot;A&quot;</td><td>null</td><td>null</td><td>&quot;04-3039129&quot;</td><td>null</td><td>12</td><td>3520</td><td>352010</td><td>35</td><td>35201010</td><td>&quot;B&quot;</td><td>&quot;MA&quot;</td><td>&quot;USA&quot;</td><td>325414</td><td>&quot;617 341 6100&quot;</td><td>null</td><td>null</td><td>1</td><td>2836</td><td>147</td><td>905</td><td>&quot;C&quot;</td><td>&quot;MA&quot;</td><td>0</td><td>&quot;www.vrtx.com&quot;</td><td>null</td><td>&quot;1991-07-24&quot;</td></tr></tbody></table></div>"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "execution_count": 19
  },
  {
   "metadata": {
    "ExecuteTime": {
     "end_time": "2025-05-19T11:09:59.447778Z",
     "start_time": "2025-05-19T11:09:59.355485Z"
    }
   },
   "cell_type": "code",
   "source": "plt.plot(vrtx['prccd'])",
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[<matplotlib.lines.Line2D at 0x116829e50>]"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ],
      "image/png": "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"
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "execution_count": 20
  },
  {
   "metadata": {},
   "cell_type": "code",
   "outputs": [],
   "execution_count": null,
   "source": ""
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.1"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
